107 related articles for article (PubMed ID: 2036238)
21. Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site.
Thangarajah F; Vogel C; Pahmeyer C; Eichler C; Holtschmidt J; Ratiu D; Mallmann P; Malter W
Anticancer Res; 2018 Oct; 38(10):6023-6026. PubMed ID: 30275235
[TBL] [Abstract][Full Text] [Related]
22. [The long-term prognosis of locally recurrent breast cancer after breast conserving treatment].
Voogd AC; Rutgers EJ; van Tienhoven G
Ned Tijdschr Geneeskd; 2006 Jan; 150(1):29-33. PubMed ID: 16440622
[TBL] [Abstract][Full Text] [Related]
23. Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action.
Kamby C; Andersen J; Ejlertsen B; Birkler NE; Rytter L; Zedeler K; Thorpe SM; Nørgaard T; Rose C
Br J Cancer; 1988 Oct; 58(4):480-6. PubMed ID: 3207602
[TBL] [Abstract][Full Text] [Related]
24. The process of metastasisation for breast cancer.
Engel J; Eckel R; Kerr J; Schmidt M; Fürstenberger G; Richter R; Sauer H; Senn HJ; Hölzel D
Eur J Cancer; 2003 Aug; 39(12):1794-806. PubMed ID: 12888376
[TBL] [Abstract][Full Text] [Related]
25. Optimal surveillance for postoperative metastasis in breast cancer patients.
Makita M; Sakai T; Ogiya A; Kitagawa D; Morizono H; Miyagi Y; Iijima K; Iwase T
Breast Cancer; 2016 Mar; 23(2):286-94. PubMed ID: 25294313
[TBL] [Abstract][Full Text] [Related]
26. The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model.
de Bock GH; Putter H; Bonnema J; van der Hage JA; Bartelink H; van de Velde CJ
Breast Cancer Res Treat; 2009 Sep; 117(2):401-8. PubMed ID: 19148746
[TBL] [Abstract][Full Text] [Related]
27. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy.
Katz A; Strom EA; Buchholz TA; Theriault R; Singletary SE; McNeese MD
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):735-42. PubMed ID: 11395242
[TBL] [Abstract][Full Text] [Related]
28. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events.
Veronesi U; Marubini E; Del Vecchio M; Manzari A; Andreola S; Greco M; Luini A; Merson M; Saccozzi R; Rilke F
J Natl Cancer Inst; 1995 Jan; 87(1):19-27. PubMed ID: 7666458
[TBL] [Abstract][Full Text] [Related]
29. The pathological findings of breast cancer in patients surviving 25 years after radical mastectomy.
Dawson PJ; Ferguson DJ; Karrison T
Cancer; 1982 Nov; 50(10):2131-8. PubMed ID: 6290024
[TBL] [Abstract][Full Text] [Related]
30. CAUSES OF DEATH IN PATIENTS WITH STAGE 0-II BREAST CANCER.
Ursaru M; Jari I; Naum A; Scripcariu V; Negru D
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):374-8. PubMed ID: 26204639
[TBL] [Abstract][Full Text] [Related]
31. [Necessity of adjuvant therapy after radical mastectomy based on a study of patients with negative nodes, who have recurrent breast cancer].
Asagoe T; Yamoto H; Nemoto A; Shikata J; Aoki A; Nakayama R; Tashiro Y
Gan No Rinsho; 1988 Jan; 34(1):41-4. PubMed ID: 3339848
[TBL] [Abstract][Full Text] [Related]
32. [Locoregional control and patterns of locoregional failure in women with breast cancer treated by highly conformal electron beam irradiation].
Loganadane G; Xi Z; Fournier-Bidoz N; Xu HP; Grellier Adedjouma N; Bazire L; Fourquet A; Kirova YM
Cancer Radiother; 2019 Feb; 23(1):38-45. PubMed ID: 30595340
[TBL] [Abstract][Full Text] [Related]
33. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.
Brantsch KD; Meisner C; Schönfisch B; Trilling B; Wehner-Caroli J; Röcken M; Breuninger H
Lancet Oncol; 2008 Aug; 9(8):713-20. PubMed ID: 18617440
[TBL] [Abstract][Full Text] [Related]
34. Basosquamous carcinoma: analysis of prognostic factors influencing recurrence.
Martin RC; Edwards MJ; Cawte TG; Sewell CL; McMasters KM
Cancer; 2000 Mar; 88(6):1365-9. PubMed ID: 10717618
[TBL] [Abstract][Full Text] [Related]
35. [A new perspective on axillary dissection in situations of metastatic sentinel node].
Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
[TBL] [Abstract][Full Text] [Related]
36. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
37. The pattern of spread and survival in 596 cases of breast cancer related to clinical staging and histological grade.
Bunting JS; Hemsted EH; Kremer JK
Clin Radiol; 1976 Jan; 27(1):9-15. PubMed ID: 177243
[TBL] [Abstract][Full Text] [Related]
38. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
39. Does Alternative and Traditional WASAM (Local cautery) Therapy Facilitate an Early and More Extensive Locoregional Metastasis of Breast Cancer?
Department of Surgery and National Oncology Center, The Royal Hospital Muscat, Sultanate of Oman
Gulf J Oncolog; 2016 Sep; 1(22):37-42. PubMed ID: 28191804
[TBL] [Abstract][Full Text] [Related]
40. Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation.
Mignano JE; Zahurak ML; Chakravarthy A; Piantadosi S; Dooley WC; Gage I
Cancer; 1999 Oct; 86(7):1258-62. PubMed ID: 10506712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
